Advertisement

Digestive Diseases and Sciences

, Volume 34, Issue 5, pp 754–757 | Cite as

Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation

  • Eran Goldin
  • Fanny Karmeli
  • ZVI Selinger
  • Daniel Rachmilewitz
Original Articles

Abstract

Substance P content was determined by radioimmunoassay in colonic mucosa from 24 patients with chronic severe constipation, 16 with active ulcerative colitis, and 28 normal controls. In patients with chronic severe constipation, the mean concentration of substance P (19.9±8.2 pg/mg) was significantly lower than in normal subjects (71±18 pg/mg). In patients with ulcerative colitis, colonic substance P concentration in inflamed mucosa (170±46 pg/mg) was significantly higher than its levels in normal subjects. Substance P may therefore have a role in the pathogenesis of clinical conditions associated with diarrhea and constipation.

Key words

substance P ulcerative colitis constipation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Vroede G: Constipation: Mechanisms and management.In Gastrointestinal Disease, 3rd ed., Vol 1. M Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders, 1983, p 288.Google Scholar
  2. 2.
    Haubrich WS: Constipation:In Bockus Gastroenterology, 4th ed., Vol 1. JE Berk (ed). Philadelphia, WB Saunders, 1985, p. 113Google Scholar
  3. 3.
    Bartho L, Holzer P: Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 16:1–32, 1985PubMedGoogle Scholar
  4. 4.
    Llewellyn-Smith IJ, Furness JB, Murphy R, O'Brien PE, Costa M: Substance P-containing nerves in the human small intestine. Gastroenterology 86:421–435, 1984PubMedGoogle Scholar
  5. 5.
    McFadden D, Zinner MJ, Jaffe BM: Substance P-induced intestinal secretion of water and electrolytes. Gut 27:267–272, 1986PubMedGoogle Scholar
  6. 6.
    Silkoff P, Karmeli F, Goldin E, Ewenson A, Gilon C, Chorev M, Laufer R, Selinger Z, Rachmilewitz D: Effect of substance P in rat gastrointestinal transit. Dig Dis Sci 33:74–77, 1988PubMedGoogle Scholar
  7. 7.
    Konturek SJ, Jaworek J, Tasler J, Cieszdowski M, Pawlik W: Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in dog. Am J Physiol 214: G74-G81, 1981Google Scholar
  8. 8.
    Laufer R, Ewenson A, Gilon C, Chorev M, Selinger Z: Inhibition of substance P degradation in rat brain preparation by peptide hydroxamic acids. Eur J Biochem 150:135–140, 1985PubMedGoogle Scholar
  9. 9.
    Mantyh PW, Goedert M, Hunt SP: Autoradiographic visualization of receptor binding sites for substance P in the gastrointestinal tract of the guinea pig. Eur J Pharmacol 100: 133–134, 1984PubMedGoogle Scholar
  10. 10.
    Bradin E, Sjolund K, Hakanson R, Sundler F: Substance P-containing nerve fibers are numerous in human but not in feline intestinal mucosa. Gastroenterology 85:557–564, 1983PubMedGoogle Scholar
  11. 11.
    Martenson HG, Akande B, Yeo Ch, Jaffe BM: The role of substance P in the control of gastric acid secretion. Surgery 95:567–571, 1984PubMedGoogle Scholar
  12. 12.
    Donnerer J, Bartho L, Holzer P, Lembeck F: Intestinal peristalsis associated with release of immunoreactive substance P. Neuroscience 11:913–918, 1984PubMedGoogle Scholar
  13. 13.
    Holzer P, Lembeck F: Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn-Schmiedeberg's Arch Pharmacol 307:257–264, 1979Google Scholar
  14. 14.
    Keast JR, Furness JB, Acosta M: Different substance P receptors are found on mucosal epithelial cells and submucous neurons of the guinea-pig small intestine. NaunynSchmiedeberg's Arch Pharmacol 329:382–387, 1985Google Scholar
  15. 15.
    Long RG, Barnes AJ, O'Snaughnessy DJ, Bannister R, Bishop AE, Albuquerque RH, McGregor GP, Polak JM, Bloom SR: Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure. Lancet 1:559–562, 1980PubMedGoogle Scholar
  16. 16.
    Powel D, Cannon P, Skrabanek P, Kirrane J: The pathophysiology of substance P in man.In Gut Hormones. SR Bloom (ed). Edinburgh, Churchill Livingstone, 1978, pp 525–529Google Scholar
  17. 17.
    Domschke S, Adrian TE, Bloom SR, Lux G, Bryant MG, Domschke W: VIP, substance P and gastrin levels of gastroduodenal mucosa in celiac sprue. Gastroenterology 82: 1044, 1982 (abstract)Google Scholar
  18. 18.
    Sjolund K, Schafalitzky OBM, Fahrenkrug J, Hakanson R, Peterson BG, Sundler F: Peptide-containing nerve fibers in the gut wall in Crohn's disease. Gut 24:724–733, 1983PubMedGoogle Scholar
  19. 19.
    Koch TR, Carney JA, Go VLW: Distribution and quantitation of gut peptides in normal colon and ulcerative colitis. Gastroenterology 86:1139, 1984 (abstract)Google Scholar
  20. 20.
    Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI: Intraneural substance P contributes to the severity of experimental arthritis. Science 226:547–549, 1984PubMedGoogle Scholar
  21. 21.
    Reynolds JC, Ouyang A, Lee AC, Baker L, Sunshine AG, Cohen S: Chronic severe constipation. Gastroenterology 92: 414–420, 1987PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Eran Goldin
    • 1
    • 2
  • Fanny Karmeli
    • 1
    • 2
  • ZVI Selinger
    • 1
    • 2
  • Daniel Rachmilewitz
    • 1
    • 2
  1. 1.Department of Gastroenterology, Hadassah University HospitalHebrew University Hadassah Medical SchoolIsrael
  2. 2.Department of Biological ChemistryThe Hebrew UniversityJerusalem

Personalised recommendations